theory clinical_96_0
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  BRAF_V600E_Mutation :: "entity ⇒ bool"
  Has :: "entity ⇒ entity ⇒ bool"
  Vemurafenib :: "entity ⇒ bool"
  Inhibitor :: "entity ⇒ bool"
  LowMolecularWeight :: "entity ⇒ bool"
  OrallyAvailable :: "entity ⇒ bool"
  ATPBindingSite :: "entity ⇒ bool"
  BRAF_V600E_Kinase :: "entity ⇒ bool"
  Bind :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  PatientEvent :: "event ⇒ entity ⇒ bool"  (* Renamed to avoid conflict *)
  Location :: "entity ⇒ entity ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Activity :: "entity ⇒ entity"
  Treatment :: "entity ⇒ bool"
  Receive :: "event ⇒ bool"
  Instrument :: "event ⇒ entity ⇒ bool"
  For :: "event ⇒ entity ⇒ bool"
  V600E_Mutation :: "entity"  (* Defined as an entity *)

(* Explanation 1: Patient has common BRAF V600E mutation. *)
axiomatization where
  explanation_1: "∃x y. Patient x ∧ BRAF_V600E_Mutation y ∧ Has x y"

(* Explanation 2: vemurafenib is a low-molecular-weight, orally available inhibitor which selectively binds to the ATPbinding site of BRAF V600E kinase and inhibits its activity. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. Vemurafenib x ∧ Inhibitor x ∧ LowMolecularWeight x ∧ OrallyAvailable x ∧ ATPBindingSite y ∧ BRAF_V600E_Kinase z ∧ Bind e1 ∧ Agent e1 x ∧ PatientEvent e1 y ∧ Location y z ∧ Inhibit e2 ∧ Agent e2 x ∧ PatientEvent e2 (Activity z)"

theorem hypothesis:
  assumes asm: "Patient x ∧ Vemurafenib z"
  (* Hypothesis: Patient could receive treatment with vemurafenib for V600E mutation. *)
  shows "∃x y z e. Patient x ∧ Treatment y ∧ Vemurafenib z ∧ Receive e ∧ Agent e x ∧ PatientEvent e y ∧ Instrument e z ∧ For e V600E_Mutation"
proof -
  (* From the premise, we have known information about the patient and vemurafenib. *)
  from asm have "Patient x ∧ Vemurafenib z" by auto
  (* Explanation 1 provides that a patient has a common BRAF V600E mutation. *)
  from explanation_1 obtain y where "BRAF_V600E_Mutation y ∧ Has x y" sledgehammer
  (* Explanation 2 provides that vemurafenib is a low-molecular-weight, orally available inhibitor, which binds and inhibits BRAF V600E kinase. *)
  from explanation_2 have "Vemurafenib z ∧ Inhibitor z ∧ LowMolecularWeight z ∧ OrallyAvailable z" <ATP>
  (* Using the logical relation Implies(B, D), we can infer that vemurafenib inhibits the activity of BRAF V600E kinase. *)
  then have "Inhibit e2 ∧ Agent e2 z ∧ PatientEvent e2 (Activity (BRAF_V600E_Kinase y))" <ATP>
  (* We can now construct the event where the patient receives treatment with vemurafenib for the V600E mutation. *)
  let ?e = "e2"
  have "Receive ?e ∧ Agent ?e x ∧ PatientEvent ?e (Treatment y) ∧ Instrument ?e z ∧ For ?e V600E_Mutation" <ATP>
  then show ?thesis <ATP>
qed

end
